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Abstract
Background: The factors contributing to chronic Chagas’ heart disease remain unknown. High nitric oxide (NO) levels have
been shown to be associated with cardiomyopathy severity in patients. Further, NO produced via inducible nitric oxide
synthase (iNOS/NOS2) is proposed to play a role in Trypanosoma cruzi control. However, the participation of iNOS/NOS2 and
NO in T. cruzi control and heart injury has been questioned. Here, using chronically infected rhesus monkeys and iNOS/
NOS2-deficient (Nos2
2/2) mice we explored the participation of iNOS/NOS2-derived NO in heart injury in T. cruzi infection.
Methodology: Rhesus monkeys and C57BL/6 and Nos2
2/2 mice were infected with the Colombian T. cruzi strain. Parasite
DNA was detected by polymerase chain reaction, T. cruzi antigens and iNOS/NOS2
+ cells were immunohistochemically
detected in heart sections and NO levels in serum were determined by Griess reagent. Heart injury was assessed by
electrocardiogram (ECG), echocardiogram (ECHO), creatine kinase heart isoenzyme (CK-MB) activity levels in serum and
connexin 43 (Cx43) expression in the cardiac tissue.
Results: Chronically infected monkeys presented conduction abnormalities, cardiac inflammation and fibrosis, which
resembled the spectrum of human chronic chagasic cardiomyopathy (CCC). Importantly, chronic myocarditis was associated
with parasite persistence. Moreover, Cx43 loss and increased CK-MB activity levels were primarily correlated with iNOS/
NOS2
+ cells infiltrating the cardiac tissue and NO levels in serum. Studies in Nos2
2/2 mice reinforced that the iNOS/NOS2-
NO pathway plays a pivotal role in T. cruzi-elicited cardiomyocyte injury and in conduction abnormalities that were
associated with Cx43 loss in the cardiac tissue.
Conclusion: T. cruzi-infected rhesus monkeys reproduce features of CCC. Moreover, our data support that in T. cruzi
infection persistent parasite-triggered iNOS/NOS2 in the cardiac tissue and NO overproduction might contribute to CCC
severity, mainly disturbing of the molecular pathway involved in electrical synchrony. These findings open a new avenue for
therapeutic tools in Chagas’ heart disease.
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Introduction
Chagas disease, which is caused by the protozoan parasite
Trypanosoma cruzi, afflicts 8–15 million individuals in endemic areas
of Latin America and several hundred thousand people in other
countries as a result of migration. Although vector transmission
has been controlled, there are still more than 50,000 new cases of
Chagas disease each year [1,2]. Despite high parasitism, which
usually declines at immunity onset, the clinical signs are usually
mild in the acute infection. After decades, most of the infected
individuals remain in the asymptomatic indeterminate form, and
,30% of the patients present arrhythmias and heart failure due to
www.plosntds.org 1 May 2012 | Volume 6 | Issue 5 | e1644end-stage dilated chronic chagasic cardiomyopathy (CCC), which
is associated with inflammation, myocytosis and fibrosis [2]. The
pathophysiological factors influencing the clinical outcome of
Chagas disease remain unclear [2]. Due to the scarcity of the T.
cruzi parasite, CCC has been associated with autoimmune
recognition of heart tissue by T-cell-enriched inflammation [3].
There is a consensus, however, that parasite persistence and/or a
parasite-driven deregulated immune response operates in CCC
[4,5]. In this context, high nitric oxide (NO) levels have been
shown to be associated with the severity of CCC in chronic
chagasic patients [6]. Nitric oxide is an important cytotoxic and
cytostatic factor in cell-mediated immunity to intracellular
pathogens [7]. Excessive NO, however, may cause host injury,
including a reduction of myocardial contractibility [8]. Nitric
oxide is formed from L-arginine by isoforms of NO synthase
(NOS): the constitutive isoforms, neuronal NOS (nNOS/NOS1)
and endothelial NOS (eNOS/NOS3), and the cytokine-inducible
NOS (iNOS/NOS2) [8]. In T. cruzi infection, in vitro and in vivo
evidence support that NO plays a pivotal role as a first line of
parasite growth control [9]. Nevertheless, iNOS/NOS2-derived
NO takes part in ventricular dilation and systolic dysfunction in T.
cruzi-elicited acute myocarditis [10]. In chagasic patients, high NO
levels have been shown to be associated with the severity of CCC
[6]. Further, iNOS/NOS2 has been shown to contribute to T.
cruzi control in acute infection [10,11]. This role, however, was
challenged in a study with iNOS/NOS2-defcient (Nos2
tm1Lau)
infected mice showing that iNOS/NOS2 is not required for
control of T. cruzi growth [12]. Moreover, iNOS/NOS2 partici-
pation in pathology has been questioned by study of gene
polymorphism at promoter region in patients [13]. Therefore,
there are doubts about the role played by iNOS/NOS2 and NO
in T. cruzi infection. Adopting the model of nonhuman primate
rhesus monkeys (Macaca mulatta) chronically infected with T. cruzi
that reproduced several clinical, parasitological and immunolog-
ical features of Chagas disease [14], we descriptively investigated
the involvement of iNOS/NOS2 and NO in Chagas’ heart
disease. Further, promptly, iNOS/NOS2-deficient mice were used
to add insights on the participation of iNOS/NOS2-derived NO
in T. cruzi-elicited heart injury.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Labora-
tory Animals of the Brazilian National Council of Animal Experi-
mentation (http://www.cobea.org.br/) and the Federal Law
11.794 (October 8, 2008). The Institutional Committee for
Animal Ethics of Fiocruz (CEUA/Fiocruz, Licenses 161/03
and 004/09) and the Biosafety National Committee (CQB/
CTNBio, License 105/99) approved all the procedures used in this
study.
Animals and infection
Seven male rhesus monkeys (Macaca mulatta,2 6 61.7 years old)
chronically infected with T. cruzi (monkeys #42, #64, #68, #90,
#95, #99, #103) were individually caged in the nonhuman
primate units (Double L Group Ltd., USA) of the Nonhuman
Primates Breeding Service (SCPRIM), of the Laboratory of
Animals Breeding Center at Fiocruz (CECAL/Fiocruz, Rio de
Janeiro, Brazil). The monkeys were provided with water ad libitum
and fed a commercial chow (Nuvilab Primates 6030, Nuvital,
Brazil) that was supplemented daily with fruits, eggs and
vegetables. Temperature, humidity and light/dark cycles were
standardized. Two noninfected age-matched male monkeys (#81
and #94) were analyzed as controls. Four noninfected male
monkeys (L17, L21, M31, N31) from our colony were used as
controls for heart function evaluations.
Metacyclic trypomastigotes of the Colombian T. cruzi strain
were used to infect the monkeys subcutaneously in the arm [15].
These animals were studied during the acute and early chronic
infection [15]. In this follow up study, the chronically infected
monkeys were analyzed at 16–19 years postinfection (ypi) and
followed for 48 months. The animals did not receive etiological
treatment for T. cruzi. Examinations and procedures were
performed under anesthesia with 10 mg/Kg ketamine chloride
(Vetaset, Fort Dodge, Iowa, USA) intramuscularly according to
the Guide for the Care and Use of Laboratory Animals (NIH Publication
No. 85-23, revised 1996). Blood was obtained by puncture of the
femoral vein with appropriate tubes (Vacutainer, Becton &
Dickinson, USA). Prior to necropsy, monkeys were sedated with
ketamine chloride and euthanized by exsanguination under deep
plane of sodium thiopental (Thiopentax, Cristalia, Belo Horizonte,
MG, Brazil). Samples of the heart and all major organs were taken
for histological studies and polymerase chain reaction (PCR) for
parasite kDNA and genomic DNA detection. For the histopathol-
ogy study, heart samples taken from five infected monkeys, which
were sacrificed at the parasitemia peak (41 days postinfection (dpi),
monkeys #37 and #67), when parasitemia was negative (70 dpi,
monkey #77, and 76 dpi, monkey #93) and 3 years postinfection
(monkey #45) used in a previous work [15] were added to our
study.
Five- to seven-week-old female C57BL/6 (H-2
b) and iNOS-
deficient (Nos2
2/2; B6.129P2-Nos2
tm1Lau/J) mice, resulted of
seven backcrossings of the original Nos2-deficient lineage in
C57BL/6 mice, were obtained from the animal facilities of
Fiocruz and were maintained in specific pathogen free conditions.
The mice were infected intraperitoneally with 100 blood
trypomastigotes of the Colombian strain [16].
Author Summary
Chagas disease, a neglected tropical disease caused by the
protozoan Trypanosoma cruzi, afflicts from 8 to 15 million
people in the Latin America. Chronic chagasic cardiomy-
opathy (CCC) is the most frequent manifestation of Chagas
disease. Currently, patient management only mitigates
CCC symptoms. The pathogenic factors leading to CCC
remain unknown; therefore their comprehension may
contribute to develop more efficient therapies. In patients,
high nitric oxide (NO) levels have been associated with
CCC severity. In T. cruzi-infected mice, NO, mainly
produced via inducible nitric oxide synthase (iNOS/
NOS2), is proposed to work in parasite control. However,
the participation of iNOS/NOS2 and NO in T. cruzi control
and heart injury has been questioned. Here, infected
rhesus monkeys and iNOS/NOS2-deficient mice were used
to explore the participation of iNOS/NOS2-derived NO in
heart injury in T. cruzi infection. Chronically infected
monkeys presented electrical abnormalities, myocarditis
and fibrosis, resembling the spectrum of human CCC.
Moreover, cardiomyocyte lesion correlated with iNOS/
NOS2
+ cells infiltrating the cardiac tissue. Our findings
support that parasite-driven iNOS/NOS2
+ cells accumula-
tion in the cardiac tissue and NO overproduction contrib-
ute to cardiomyopathy severity, mainly disturbing the
pathway involved in electrical synchrony in T. cruzi
infection.
iNOS and NO in Chagas’ Heart Disease
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The classic 12-lead human electrocardiogram (ECG) system
was used to analyze rhesus monkeys. Tracings were made at
25 mm/s at a voltage of 1 mV standardized to 1 cm (ECG-6,
Ecafix, Brazil) [14]. Two-dimensional and M-mode echocardio-
gram (ECHO) was performed on a regular basis and recorded
with a multi-image camera (Ultrasound Scanner EUB-555,
Hitachi, Japan). The ventricular function was assessed in the M-
mode, by calculating the ejection fraction, and in the bidimen-
sional mode, by semiquantitatively analyzing the global systolic
function [14]. Electrocardiogram, ECHO and radiology (chest,
esophagus, colon) were performed at 12-month intervals.
Mice were intraperitoneally tranquilized with diazepam
(20 mg/Kg), and transducers were placed under the skin for DII
derivation. Electrocardiogram traces were recorded during two
minutes using Power Lab 2/20 (PanLab Instruments, Spain),
analyzed with Scope Software for Windows v3.6.10 (PanLab
Instruments, USA) [16] and independently analyzed by two
investigators.
Histopathology studies
Tissue fragments were fixed in 10% formalin, processed, and
embedded in paraffin. Tissue sections (5 mm) were stained with
hematoxylin and eosin (H&E) and immunohistochemically (IHS)
stained. To evaluate collagen deposits, heart sections were stained
with Siriusrot F3B (Chroma Gessellschaft, Germany) in a
saturated aqueous solution of picric acid and fast green. The
proportion of collagen-positive areas was evaluated with the digital
morphometric apparatus and analyzed with AnalySIS AUTO
Software (Soft Imaging System, USA).
Immunohistochemical staining
A polyclonal anti-iNOS/NO2 antibody was obtained from
Cayman Chemical (#160862, USA), and an anti-connexin 43a1
(Cx43) polyclonal antibody was purchased from Sigma (#C6219,
USA). In addition, a polyclonal antibody recognizing T. cruzi
antigens was produced in rabbits (LBI/IOC-Fiocruz, Brazil). A
biotinylated anti-rabbit and peroxidase-streptavidin complex was
purchased from Amersham (England). Antibodies and reagents
were utilized in compliance with the manufacturers’ instructions.
Serial 5-mm sections were subjected to standardized IHS [16].
The material was counterstained with Mayer’s hematoxylin. The
T. cruzi-, iNOS/NOS2- or Cx43-positive areas in 25 fields
(12.5 mm
2) per section, in 3 sections per heart, were evaluated
with a digital morphometric apparatus. For the quantitative
studies of Cx43 expression only areas with preserved myocardial
cells were analyzed. The images were analyzed with AnalySIS
AUTO Software (Soft Imaging System, USA). The areas that
expressed the molecule of interest were integrated with the areas
that did not express the molecule of interest, and the data were
presented as the percentage of the positive area.
DNA extraction and PCR conditions
Two or three different tissue samples per studied organ were
processed separately for DNA extraction, and the purified DNA
was PCR amplified using T. cruzi-specific kDNA minicircle
primers [14] or analyzed by real time quantitative PCR (qPCR)
using primers directed to the nuclear satellite DNA [17]. DNA
integrity and the possible presence of PCR inhibitors were checked
by amplification of the human b-globin sequence [14]. Samples
showing no amplification for b-globin were retested after a new
DNA extraction. For the real time PCR assays heart and spleen
samples (of one to two cm
3) kept in liquid nitrogen were sectioned
using a cryostat in conditions to avoid DNA cross-contamination
and the studied area calculated using the AnalySIS AUTO
Software (Soft Imaging System, USA). As negative and positive
controls, respectively, heart tissues from noninfected C57BL/6
mice or mice at 50 dpi with the Colombian T. cruzi strain were
used [16].
The qPCR experiments were performed using the ABI Prism
7500 Fast (Applied Biosystems, USA), in a final volume of 20 mL
containing 2 mL DNA samples and 10 ml GoTaq qPCR Master
Mix (Promega, USA). Primers Cruzi 1 and Cruzi 2 were used for
the T. cruzi nuclear satellite target [17]. The cycling conditions
were as follows: 95uC for 10 minutes, followed by 40 cycles at
95uC for 15 seconds and 58uC for 1 minute. After amplification,
the specificity of these primers was confirmed through melting
curve analysis of the generated amplicons, revealing a solely
melting temperature (Tm) for the amplified fragment. Each
sample submitted to qPCR analysis was performed in triplicates
and the results were expressed as mean values. Parasitic load
quantification was obtained by absolute quantification of T. cruzi
DNA, following normalization of the heart and spleen analyzed
Table 1. Electrocardiographic patterns detected in Trypanosoma cruzi-infected rhesus monkeys during acute and chronic
infection.
Acute phase
* Chronic phase
Monkeys
Weeks
p.i.
Heart
condition
Years
p.i.
Heart
condition
Years
p.i.
Heart
condition Years p.i.
Heart
condition
Years
p.i.
Heart
condition
42 8–12 AVB, RBBB
{ 19 AVR 20 Normal 20 Sacrificed - -
64 20 Normal 19 AVR 20 Normal 22 Normal 23 Normal
68 4–12 AVB, RBBB,LvQRS 18 Sacrificed - - - - - -
99 20 Normal 16 Normal 17 Normal 19 Normal 20 Normal
103 6–8 AVB, AVR 16 Normal 17 AVB, AVR 19 AVB 20 RBBB
90 4–8 AVB,LvQRS 16 Ventricular
extrasystoles, AVR
17 Atrial extrasystoles,
AVR
19 AVR 20 LBBB,AVR
95 4–12 AVB, AVR 16 LBBB 17 LBBB, AVR 19 LBBB 20 LBBB, AVR, RAD
*[15].
{ECG patterns were evaluated using the following standard criteria: AVB - atrioventricular block, AVR - Abnormal ventricular repolarization, LBBB - Left bundle branch
block - second-degree His bundle, LvQRS - Low voltage QRS, RBBB - right bundle branch block - first-degree His bundle, RAD - right QRS axis deviation.
doi:10.1371/journal.pntd.0001644.t001
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of DNA extracted from T. cruzi Colombian epimastigotes culture
stocks, ranging from 10
6 to 10 parasite equivalents.
Total IgG and IgM and specific anti-T. cruzi serology
The levels of total IgG and IgM were determined by kinetic
nephelometry (Beckman Coulter Array 360, Beckman Coulter,
USA) in accordance with the manufacturer’s instructions. Specific
anti-T. cruzi IgG antibodies were measured by ELISA (EIE-
Chagas, BioManguinhos, Fiocruz, Brazil) in accordance with the
manufacturer’s instructions.
Nitric oxide quantification
Nitrate and nitrite were determined in plasma samples from
noninfected and infected monkeys using Griess reagent and
vanadium chloride III with a standard curve of 0.8–100 mM
NaNO2 and NaNO3 [18].
Creatine kinase detection
The activity of the CK-MB isoenzyme was measured in serum
with a commercial kit (Labtest, Brazil) according to the
manufacturer’s recommendations. The optical density at 340 nm
(Microplate Reader Benchmark, Bio-Rad, USA) was recorded
every 2 minutes for 15 minutes [16].
Statistical analysis
Data are expressed as arithmetic mean 6 SD. Student’s t test
was adopted to analyze the statistical significance of the apparent
differences. All statistical tests were performed with SPSS 8.0
software. Differences were considered statistically significant at
p,0.05.
Results
Spectrum of clinical forms of chronic Chagas disease is
reproduced in Trypanosoma cruzi-infected rhesus
monkeys
The general characteristics of the studied monkeys are shown in
Table S1. Electrical conduction abnormalities found in acute and
chronically T. cruzi-infected monkeys are summarized in Table 1.
Interestingly, the mild electrical abnormalities that we detected
during the acute T. cruzi infection disappeared at the 4
th month
postinfection [15]. In this follow up study, during the chronic
infection (18–23 ypi), three monkeys (#42, #64 and #68) showed
transient electrical alterations, and three animals (#90, #95 and
#103) presented significant electrical conduction abnormalities.
The ECG patterns were normal in the 4 analyses of one monkey
(#99). In infected monkey #90, multiform ventricular extrasys-
toles were observed at 16 ypi, atrial extrasystoles were observed at
17 ypi, an incomplete left bundle branch block (LBBB) was
observed at 20 ypi, and T-wave inversion was observed in all 4
analyses. In monkey #103, first-degree atrioventricular (AV)
conduction disturbance and T-wave inversion were seen at 17 ypi.
In monkey #95, LBBB was seen in the 4 exams, and the T-wave
inversion was more accentuated and right QRS axis deviation at
20 ypi. Representative ECG registers of chronically T. cruzi-
infected are shown in Figure S1. As shown in Table S2, only
monkey #95 showed ECHO abnormality with asynchronic
interventricular septum motility and a decreased left ventricular
ejection fraction (72.4% and 53.2% at 16 ypi and 17 ypi,
respectively). Altogether, monkeys #42, #64, #68 and #99 were
considered non-cardiopatic and monkeys #90, #95 and #103
were considered cardiopatic. All T. cruzi-infected monkeys showed
normal radiological exams of the chest, esophagus and colon at the
end-point of this study (data not shown). Therefore, monkeys #42,
#64, #68 and #99 presented the indeterminate form of the
chronic Chagas disease.
Trypanosoma cruzi-infected rhesus monkeys presented
histopathological alterations compatible with chronic
chagasic cardiomyopathy
In the acute infection, intense heart parasitism was associated
with pronounced inflammatory infiltrates at 41 dpi (monkeys #37
and #67). This effect subsided at 76dpi (monkey #93), which
coincided with parasitemia control. Inflammation was focal or
absent at 3 ypi (monkey #45) [15]. In the chronic infection, none
of the analyzed organs showed macroscopic alterations. In
addition, no ventricular conduction system alteration was observed
in the analyzed areas of the fibers composing the bundle of His in
chronically T. cruzi-infected rhesus monkeys (data not shown). The
main histopathological alterations found in the cardiac tissue are
represented in the Figure S2. In monkeys with electrical
abnormalities (#90, #95 and #103) and decreased left ventricular
ejection fraction (#95), histopathological alterations were hetero-
geneous with areas with normal aspect (Figure S2E), but mostly
areas with a mild or intense multifocal myocarditis (more
pronounced in the left ventricle), with lymphocytes, macrophages,
and an apparent lack of parasites, was associated with the
disrupted spaces between cardiomyocytes and hypertrophy of the
myocardial fibers (Figure S2D, Figure S2F). Further, monkeys
with the indeterminate form of Chagas disease presented focal
myocarditis (Figure S2A, Figure S2B) or complete absence of
cardiac inflammation or myocardial fiber injury (Figure S2C).
Conversely, noninfected controls (Figure S2G) consistently did not
have inflammation or myocardial fiber injury.
Compared with noninfected controls (Figure 1A, Figure 1G),
myocardial fibrosis with collagen deposits was detected in the early
(41 dpi) acute infection (Figure 1B, Figure 1G). Fibrosis was
residual in the early (3 ypi) chronic infection (Figure 1C, Figure 1G)
and characterized the indeterminate form of the disease. In the
late (20 ypi) chronic infection, the monkey that had transient
alterations in clinical score (#64) presented intense fibrosis
(Figure 1D, Figure 1G), while in the monkey with normal clinical
score (#99) heart histological aspects and collagen deposits
resembling those of noninfected controls (Figure 1E, Figure 1G).
In the cardiopatic monkeys (#90, #95 and #103), fibrosis
(Figure 1F, Figure 1G) was related to the severity of electrical
abnormalities. Collagen deposits varying from slight to severe were
Figure 1. Increased collagen deposits in the myocardium of T. cruzi-infected rhesus monkeys. Collagen deposition was used to assess
fibrosis in the myocardium of the left ventricle of noninfected and T. cruzi-infected monkeys. (A) Noninfected monkey #94, normal slight collagen
deposits. (B) Monkey #67 (41 dpi), increased collagen deposition. (C) Monkey #45 (3 ypi), normal collagen deposits. (D) Monkey #64 (23 ypi),
increased collagen deposition. (E) Monkey #99 (20 ypi) normal slight collagen deposits. (F) Monkey #95 (20 ypi), increased interstitial matrix
deposits. G. Percentage of cardiac section area occupied by collagen deposits in the myocardium of the left ventricle of noninfected and T. cruzi-
infected monkeys. (H–K) Serial heart sections of monkey #95 (20 ypi) showing: (H) intense infiltrates of mononuclear inflammatory cells (I)
paralleling fibrosis, and (J) substitution of cardiomyocytes by mesenchymal cells in (K) an area of intense fibrosis. A–F, I and K, Picro-Sirius red stain.
H and J, H&E. Bar=100 mm.
doi:10.1371/journal.pntd.0001644.g001
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www.plosntds.org 5 May 2012 | Volume 6 | Issue 5 | e1644Figure 2. Persistence of T. cruzi in chronically infected rhesus monkeys. The persistence of T. cruzi parasite and antigens was evaluated by
immunohistochemistry, PCR and antibody response. (A) Photomicrographs of section of myocardium of left ventricle of monkey #95 (20 ypi).
Immunohistochemistry for T. cruzi antigens (black arrows and insert) associated (dotted square) or not associated (black arrow) with focal
inflammation. Inflammatory infiltrates lacking parasite antigens (white arrow heads). B–C. PCR for T. cruzi kDNA (,330 bp) in blood of noninfected
controls (NI) and T. cruzi-infected rhesus monkeys at (B) 16–20 ypi and (C) 20–23 ypi. (D) PCR for T. cruzi kDNA (,330 bp) in fragments of the left
ventricle (LV) of the heart of noninfected controls and T. cruzi-infected rhesus monkeys at 20–23 ypi. Negative (2) and positive (+) controls were heart
fragments of noninfected and T. cruzi-infected C57BL/6 mice, respectively. (E) Real time qPCR for the T. cruzi satellite DNA sequences Cruzi1/Cruzi2 in
iNOS and NO in Chagas’ Heart Disease
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areas of severe inflammation (Figure 1H), fibrosis was abundant
(Figure 1I), and there was substitution of cardiomyocytes by
mesenchymal cells (Figure 1J) and dense bundles of interstitial
matrix that extended from the subepicardium into the subjacent
myocardium (Figure 1K). Therefore, in six out of seven T. cruzi-
infected rhesus monkeys, clinical and histological alterations were
compatible with chronic Chagas disease. Interestingly, three of
these monkeys reproduced major aspects of CCC in patients
[2,19].
Parasite persistence in chronically Trypanosoma cruzi-
infected monkeys
Exhaustive microscopic examinations of paraffin heart tissue
sections failed to detect T. cruzi pseudocysts or isolated amastigotes
in all of the chronically infected monkeys. Immunohistochemistry
experiments were performed to detect T. cruzi antigens, and
extramyocytic antigens were seen as red amorphous spots
(Figure 2A) in six out of seven infected animals (the exception
was monkey #99). T. cruzi antigens were commonly surrounded
by mononuclear cell infiltrates (Figure 2A, black arrows); however,
inflammatory cells were also seen associated to apparently
noninfected fibers (Figure 2A, white arrow heads). In addition,
blood samples and fragments of spleen and cardiac tissue were
submitted to conventional PCR amplification targeting T. cruzi
kDNA minicircles [14]. In the 1
st analysis (16–19 ypi) of blood, all
T. cruzi-infected animals showed a PCR signal at ,330 bp for
kDNA, whereas the noninfected monkeys (#81 and #94) did not
show a signal (Figure 2B). In the 4
th analysis (20–23 ypi), a PCR
signal at ,330 bp was detected in the blood of six infected rhesus
monkeys (Figure 2C). Furthermore, T. cruzi kDNA was identified
in the cardiac septum, left (Figure 2D) and right ventricles, left and
right atria, and aorta of all infected monkeys except monkey #99.
All of the infected monkeys were parasitologically positive for T.
cruzi at 16–19 ypi [14]. At 20 ypi, however, attempts to identify T.
cruzi kDNA in the blood and heart of monkey #99 were
consistently negative (Figure 2C, Figure 2D). Considering that
low parasitism could contribute to these results, we performed
additional studies using two or three tissue samples per analyzed
monkey. Real time qPCR for the conserved repetitive nuclear
satellite DNA sequences revealed low parasitism in heart samples
of all T. cruzi-infected rhesus monkeys except monkey #103.
Conversely, real time qPCR revealed low parasitism in spleen
samples of all T. cruzi-infected monkeys (Figure 2E, Figure 2F).
Heart and spleen samples of noninfected controls were repeatedly
negative (Figure 2E). The b-globin sequence was detected as a
control for DNA integrity and PCR inhibition in all analyzed
samples (data not shown). Taken together, these results support
parasite persistence in indeterminate (#42, #64, #68, #99) and
cardiopatic (#90, #95, #103) chronically T. cruzi-infected rhesus
monkeys. Because antibody detection is a criterion for persistent
infection [20], we analyzed the kinetics of the anti-T. cruzi
antibody in a group of infected monkeys that were cardiopatic
(#90, #95 and #103) and a monkey that was indeterminate
(#99) at 20 ypi. Figure 2G shows that all monkeys were
seronegative prior to infection. The anti-T. cruzi antibody was
only detected in one monkey (#103) when parasitemia was
positive (18 dpi). When parasitemia was controlled (59 dpi) [15] all
of the infected monkeys presented anti-T. cruzi antibodies. At the
end-point of our study, anti-T. cruzi antibodies were detected in
cardiopatic monkeys (#90, #95, #103), but not in indeterminate
monkey #99. Importantly, there were no alterations in the levels
of total IgM (Figure S3A) and IgG (Figure S3B) in serum of T.
cruzi-infected monkeys in comparison with noninfected controls at
the end-point of this study (20–23 ypi).
iNOS/NOS2
+ cells in the cardiac tissue and high NO levels
in serum are associated with cardiomyopathy in
chronically Trypanosoma cruzi-infected monkeys
Because parasite antigens were scarce in the cardiac tissues of
monkeys with the indeterminate and cardiac forms of Chagas
disease, we evaluated the cardiac tissue for the expression of
iNOS/NOS2, which is an enzyme potentially involved in an
important parasite control pathway [9,11]. Analysis of serial heart
tissue sections revealed that most of the iNOS/NOS2
+ cells
infiltrating the myocardial interstitium of infected animals
(Figure 3A–D) were CD68
+ macrophages (data not shown). There
was a significant increase in the number of iNOS/NOS2
+ cells in
the myocardium of monkey #95 that presented high parasitism
detected by qPCR for genomic DNA (Figure 3A–D, Figure 3E),
whereas iNOS/NOS2
+ cells were scarce or absent in noninfected
animals (Figure 3E).
In chronic Chagas disease, severity of CCC correlated with high
NO levels in serum [6]. Because an increased number of iNOS/
NOS2
+ cells in the cardiac tissue of infected monkeys was related
to the severity of electrical abnormalities, we decided to study NO
levels in the serum of infected monkeys. A high NO concentration
was only detected in the monkey (#95) with severe CCC
(Figure 3F). In this monkey, parasite control was achieved at 2
months postinfection, at which point antibodies were detected
(Figure 2G), in absence of significant NO concentration in serum
(Figure 3G). A high NO concentration was only detected after 6
months of infection, and the NO level was persistently elevated at
16 and 20 ypi (Figure 3G). In the case of noninfected monkeys
#81 and #94 the low numbers of iNOS/NO2
+ cells in the
cardiac tissue was parallel to low NO levels in serum (Figure 3E,
Figure 3F). In the cardiopatic T. cruzi-infected monkey #95 the
high number of iNOS/NO2
+ cells in the cardiac tissue paralleled
the high NO concentration in serum (Figure 3E, Figure 3F).
However, there was no significant correlation (r
2=0.5206,
p=0.105) between the number of iNOS/NO2
+ cells in the
cardiac tissue and NO concentration in serum of T. cruzi-infected
rhesus monkeys.
Cardiac tissue injury is severe in Trypanosoma cruzi-
infected monkeys overexpressing iNOS/NOS2 and NO
Overexpression of iNOS/NOS2 and NO has been shown to be
associated with heart injury in noninfectious conditions [8]. To test
the possible consequences of iNOS/NOS2 overexpression in the
heart tissue of T. cruzi-infected monkeys, we analyzed the
expression of Cx43. Connexin 43 is the major gap junction
protein in the heart, and Cx43 is primarily responsible for the
electrical synchrony of cardiomyocytes [21]. Connexin 43
distribution was homogeneous in the intercalated disks of
heart and spleen of noninfected controls and T. cruzi-infected rhesus monkeys at 20–23 ypi. (F) Standard curve of 10-fold serial dilution of DNA of
epimastigote forms of the Colombian T. cruzi strain (10
6 to 10 parasites/mL) used for the absolute quantification by real time qPCR. The linear
regression curve, coefficient of determination (r
2=0.995) and qPCR efficiency (E=80%) are indicated. The melting curve is also shown. (G) Serology
for IgG anti-T. cruzi in rhesus monkeys prior to infection, during the acute phase (AP), when parasitemia was positive (+) and negative (2), and during
the chronic phase (CP; at the end-point 20 ypi). Bar=100 mm; Bar=25 mm in insert in (A).
doi:10.1371/journal.pntd.0001644.g002
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Cx43 pattern and stained area in the indeterminate T. cruzi-
infected monkeys 64 (Figure 4B) and #99 (Figure 4C) were
preserved, and the Cx43 staining resembled the noninfected
controls (Figure 4G). Conversely, Cx43 was detected as disorga-
nized patches scattered throughout the tissue of cardiopatic
infected monkeys #90 (Figure 4D), #95 (Figure 4E, Figure 4F)
and #103 (data not shown). In addition, Cx43 loss was associated
with inflammatory infiltrates (Figure 4E, Figure 4F). Although not
considered for the quantitative study, in cardiac areas where
myocardial cells were substituted by mesenchymal cells Cx43 loss
was, obviously, more pronounced (Figure 4F). Monkey #95,
which showed the more severe form of CCC and a high number of
iNOS/NOS2
+ cells in the heart, also exhibited a marked Cx43
loss (Figure 4E, Figure 4F, Figure 4G). Interestingly, when the
percentage of Cx43-stained area in the cardiac tissue was
evaluated considering the clinical score, significant Cx43 loss
was detected in cardiopatic T. cruzi-infected monkeys
(0.9260.12% of stained area) when compared with indeterminate
(2.2560.31% of stained area; p,0.05) and noninfected
(2.0660.18% of stained area; p,0.05) rhesus monkeys. Increased
CK-MB activity levels in serum, which is a marker of myocardial
cell injury [22], was detected in cardiopatic monkeys #95 and
#103 (Figure 4H). In the infected monkeys with normal ECG
patterns (#64 and #99), the CK-MB activity levels resembled the
levels in the noninfected controls (#81 and #94). A positive
correlation was seen between the Cx43 loss in the cardiac tissue
and the CK-MB activity levels in serum of the studied rhesus
monkeys (r
2=0.6355; p,0.05). Importantly, there was a positive
correlation between the number of iNOS/NOS2
+ cells in the
heart tissue and the CK-MB activity level in the serum
(r
2=0.8263; p,0.05) of chronically T. cruzi-infected rhesus
monkeys (Figure 4I).
Decreased myocardial cell lesion and heart injury in
iNOS/NOS-deficient mice
To add insights on the participation of iNOS/NOS2-derived
NO in T. cruzi-elicited cardiomyopathy, we studied the effect of
the infection of iNOS/NOS2-deficient (Nos2
tm1Lau/J) mice in
different aspects of heart injury. After 40 days of infection, in
comparison with noninfected controls wild-type C57BL/6 mice
present increased NO levels in serum (Figure 5A), which are not
detected in Nos2
2/2 mice (4.460.17 mM in noninfected vs.
4.362.1 mMi nT. cruzi-infected). In addition, there was an
increased number of iNOS/NOS2
+ cells in the cardiac tissue of T.
cruzi-infected C57BL/6 mice (Figure 5B). Interestingly, a signifi-
cant increase (p,0.05) in the number of parasite nests was seen in
the cardiac tissue of Nos2
2/2 mice (Figure 5C). Further, a similar
intensity of myocardial inflammation (Figure 5D) and frequency of
ICAM-1
+ and VCAM-1
+ blood vessels (data not shown) were
detected in wild-type and Nos2
2/2 mice. Representative ECG
registers at 40 dpi are shown in the Figure S4. Absence of iNOS/
NOS2 led to sinus bradyarrhythmia in noninfected controls
compared with noninfected wild-type C57BL/6 mice. Further, T.
cruzi-infected C57BL/6 and Nos2
2/2presented increased PR
interval, resulting in first-degree AV block (Table 2). Importantly,
T. cruzi-infected mice showed concomitantly two types of
arrhythmia, sinus bradycardia and AV block. Significant increase
in QTc and higher QRS scores were detected in T. cruzi-infected
C57BL/6 mice compared with noninfected mice (Table 2).
Interestingly, changes in QRS scores were significantly decreased
in infected Nos2
2/2 mice compared with infected C57BL/6 mice
(Table 2, p,0.001). Altogether, T. cruzi infection resulted in more
frequent first- and second- degree atrioventricular block type 2:1 in
infected C57BL/6 mice compared with infected Nos2
2/2 mice
(Table 2). Considering the importance of myocardial cell integrity
for electrical conduction and the participation of Cx43 in this
process (21), we analyzed the CK-MB levels in serum and
Cx43expression in the cardiac fibers of iNOS/NOS2 deficient T.
cruzi-infected mice. Importantly, when compared with infected
C57BL/6 mice, Nos2
2/2 mice had a significant decrease in CK-
MB activity levels in serum (Figure 5E), although myocardial cell
lesion was not completely abrogated. Additionally, absence of
iNOS/NOS2 resulted in inhibition of Cx43 loss in the cardiac
tissue of T. cruzi-infected mice (Figure 5F). Taken together, these
data reveal decreased cardiomyocyte lesion and more preserved
heart conduction and ventricle polarization in T. cruzi-infected
mice with iNOS/NOS2 deficiency.
Discussion
In the present study, the infection of nonhuman primate rhesus
monkeys with the Colombian T. cruzi strain reproduced clinical
and histopathological aspects of the chronic indeterminate and
cardiac forms of Chagas disease, including parasite persistence in
the cardiac tissue. Moreover, overexpression of iNOS/NOS2 cells
in the cardiac tissue and systemic high NO levels were directly
related to cardiomyocyte lesion and heart injury, including
electrical abnormalities. Studies in Nos2
2/2 mice corroborated
the participation of iNOS/NOS2 in parasite dissemination control
and, moreover, revealed the participation of the iNOS/NOS2-
derived NO in disturbance of the major molecular pathway
involved in electrical synchrony in T. cruzi infection.
The reproduction of several features of CCC, which is the main
clinical manifestation of Chagas disease, in T. cruzi-infected rhesus
monkeys allows the adoption of this model to test vaccines and
new trypanocide chemotherapies. In addition, T. cruzi-infected
rhesus monkeys can be used to investigate mechanisms of CCC
physiopathology [1]. Although the outbred nature and small
number of monkeys can be viewed as a limitation of the present
studies, these animals reproduced the clinical spectrum (indeter-
minate and cardiac form) seen in Chagas disease [2,19].
Moreover, the chronically infected monkeys reproduced the most
typical chagasic electrical conduction abnormalities [2]. Although
no increase in the cardiothoracic index was noticed in infected
monkeys, asynchronic interventricular septum motility was
detected in monkey #95, which showed a more severe stage of
CCC. Electrical conduction alterations were associated with the
intensity of myocardial fibrosis, which was spatially related to
inflammation in an apparent lack of parasite and resembled the
features of Chagas disease [2,19]. Myocardial fibrosis was directly
Figure 3. iNOS/NOS2
+ cells in the myocardium and NO in the serum of T. cruzi-infected rhesus monkeys. The presence of iNOS/NOS2
+
cells in the myocardium of the left ventricles was immunohistochemically detected and NO concentration was evaluated by a Griess-based method.
Photomicrograph of myocardium section of the left ventricle (A) and (B) of the noninfected monkey #81, which showed a few iNOS/NOS2
+ cells.
Photomicrograph of myocardioum section of the left ventricle (C) and (D) of the T. cruzi-infected monkey #95 (20 ypi). (E) Number of iNOS/NOS2
+
cells in 100 microscopic fields in heart sections. (F) Concentration of NO in the serum of noninfected controls and chronically (20–23 ypi) T. cruzi-
infected monkeys. (G) Concentration of NO in the serum of monkey #95 prior to infection (day 0), during the acute phase when parasitemia was
positive (56 dpi) and negative (163 dpi) and during the chronic phase (16 ypi and 20 ypi). Bar=100 mmi n( A) and (C); Bar=25 mmi n( B) and (D).
doi:10.1371/journal.pntd.0001644.g003
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www.plosntds.org 9 May 2012 | Volume 6 | Issue 5 | e1644Figure 4. Cardiomyocyte injury in T. cruzi-infected rhesus monkeys. Cardiomyocyte damage was assessed by immunohistochemical
detection of Cx43 in the myocardium of the left ventricle and CK-MB activity levels in the serum of noninfected and chronically T. cruzi-infected
rhesus monkeys. (A) Photomicrograph of myocardium section of the left ventricle of the noninfected monkey #94 showing normal pattern of Cx43
expression in intercalated discs. (B) Photomicrograph of myocardium section of the left ventricle of the T. cruzi-infected monkey #64 (23 ypi)
showing normal aspect. (C) Photomicrograph of left ventricle section of the T. cruzi-infected monkey #99 (20 ypi) showing normal Cx43 pattern. (D)
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Chagas’ heart disease [23]. Fibrosis, which is one of the most
important features of CCC [19], shows a progressive evolution in
T. cruzi-infected mice [24]. Fibrosis is directed by inflammatory
processes that provoke chemokine-driven accumulation of mesen-
chymal cells [25]. In the present studies, collagen deposition
occurred early in the acute infection (41–76 dpi) concomitantly
with inflammation. Interestingly, inflammation resolution and
collagen degradation can occur without specific treatment. This
finding was seen in monkey #45, which presented the indeter-
minate form of Chagas disease at 3 ypi. Monkey #99 did not
exhibit cardiac inflammation or fibrosis; however, we could not
prove whether fibrosis was established and later remodeled. The
predominance of type III, pro-III, and pro-IV collagens in the
heart tissue of individuals with chronic T. cruzi infection [24] may
favor reversibility of fibrosis because these collagens have a high
turnover. In T. cruzi infection, extracellular matrix deposition in
the cardiac tissue can be remodeled if inflammation subsides,
which has been observed after etiological chemotherapy with
benznidazole in the chronic infection [24] and after modulation of
inflammation with a partial CC-chemokine receptor antagonist in
the acute and chronic infection [26,27]. These data suggest
parasites and inflammation as triggers of fibrogenic factors in
CCC, which reinforces the idea that therapeutic strategies
targeting parasites and inflammation, possibly combined, may be
beneficial in remodeling fibrosis and restoring heart function in
Chagas disease.
Observations of chronic myocarditis and fibrosis in the apparent
absence of T. cruzi have suggested that autoimmunity is a central
mechanism for CCC pathogenesis [3]. In a classic study, however,
amastigote forms of T. cruzi were detected inside myocardial cells
in all analyzed CCC patients [19]. Furthermore, a PCR signal for
T. cruzi kDNA has been observed in the hearts of CCC patients,
but it was not detected in seropositive nonCCC patients [28]. In
indeterminate and cardiopatic T. cruzi-infected monkeys, parasites
(antigen, kDNA and nuclear satellite DNA) persisted in the heart
and spleen. Although in some tissue samples parasite kDNA was
not detected in repeated analyses, the study of different fragments
of heart and spleen and the use of more sensitive assay resulted in
detection of parasite persistence in all chronically T. cruzi-infected
rhesus monkeys. Considering the short life span of parasite DNA
in host tissues [29], PCR signals in the heart and spleen of infected
monkeys constitute real proof of T. cruzi persistence. The presence
of anti-T. cruzi antibodies in cardiopatic monkeys coincided with
parasite persistence in the blood, heart and spleen. In monkey
#99, however, anti-T. cruzi antibodies were restricted to the acute
infection and coincided with parasite control. Detection of a
specific immune response in chronically infected individuals
reflects continuous antigenic stimulus by persistent parasites. The
consistent absence of detection of specific antibodies [15], T. cruzi
kDNA in peripheral blood and heart in monkey #99, which had
no electrical abnormalities, cardiac inflammation or fibrosis at 20
ypi in the absence of treatment, led us to consider the possibility of
spontaneous cure in this monkey [19]. However, the analysis of
different fragments of spleen and heart revealed the presence of T.
cruzi genomic DNA in both tissues of monkey #99, supporting the
persistence of parasite in these tissues in this monkey with the
indeterminate form of Chagas disease. Therefore, the low
parasitism restricted to focal areas in different organs may explain
the difficulties to reveal parasite and antibodies presence in this
monkey.
Although there was no correlation between the quantity of
antigens and the intensity of myocarditis, the detection of T. cruzi
DNA in the cardiac tissue of infected monkeys supports the idea
that persisting parasites trigger detrimental inflammation that can
act on cardiomyocytes. Heart inflammation is a major factor that
contributes to an increased risk of death in CCC compared with
other heart conditions [30]. The components of inflammatory
infiltrates contributing to this picture remain unclear. In nonin-
fectious human diseases and murine models of cardiac pathologies,
iNOS/NOS2 and NO were shown to be both protective and
detrimental for heart physiology, and these effects may be
dependent on NO concentration [8,31]. Therefore, the increased
number of iNOS/NOS2
+ cells in the heart tissue of T. cruzi-
infected cardiopatic monkeys led us to search for cardiomyocyte
lesion. Connexin 43 was severely depleted in cardiopatic monkey
#95, which presented a high number of iNOS/NOS2
+ cells
infiltrating the cardiac tissue. T. cruzi infection of human
cardiomyocytes in vitro [32] and mice in vivo [27,33] has also been
shown to cause Cx43 loss. This effect was hampered in infected
TNFR1-deficient T. cruzi-infected mice, which supports that
TNF/TNFR1 signaling is involved in Cx43 loss [33]. Tumor
necrosis factor, particularly associated with IFNc, is an iNOS/
NOS2 inducer that results in NO production [7,8]. In this context,
we detected IFNc in the serum of monkey #95 (150 pg/mL) and
TNF in the serum of monkey #103 (28 pg/mL) and high IFNc
and TNF levels in PMA-stimulated peripheral blood cells of
monkeys #103 and #95, but not in noninfected controls or
infected monkeys with the indeterminate form of Chagas disease
(our unpublished data). Although consistent with the idea that the
cardiopatic monkeys #103 and #95 overproduce inflammatory
cytokines that may stimulate NO production, the low number of
responsive animals hampered any definitive conclusion. Thus, the
mechanism by which high iNOS/NOS2 is induced in cardiac
tissue following T. cruzi infection remains unknown. The present
study was the first to show that in CCC the numbers of iNOS/
NOS2
+ cells in cardiac tissue are associated with Cx43 loss and,
more clearly, with increased CK-MB activity levels in serum,
markers of cardiomyocyte injury [21,22]. Interestingly, iNOS/
NOS2 upregulation in an inflammatory milieu results in increased
NO levels in the cardiac tissue in autoimmune myocarditis [34]. In
addition, NO is induced in macrophages and cardiomyocytes by
T. cruzi and inflammatory cytokines and chemokines, which
require the iNOS/L-arginine pathway [35]. The severity of CCC
is associated with high NO levels in chagasic patients [6]. Nitric
oxide has also been shown to be involved in heart denervation in
acute T. cruzi infection in rats [31]. Therefore, persistent T. cruzi in
the cardiac tissue might sustain continuous iNOS/NOS2 expres-
sion and a large supply of NO in a tissue that normally experiences
low and tightly controlled levels of this mediator [7,36]. In
consequence, the increased expression of iNOS/NOS2 and supply
of NO could lead to cardiomyocyte lesion and heart injury. To test
Photomicrograph of section of left ventricle of the T. cruzi-infected monkey #90 (20 ypi) revealing Cx43 loss in myocardial area lacking inflammation.
(E–F). Photomicrographs of left ventricle section of the cardiopatic T. cruzi-infected monkey #95 (20 ypi) showing Cx43 loss in area with (E) intense
diffuse inflammation and (F) the substitution of cardiomyocytes by mesenchymal cells. (G) Frequency of stained Cx43 area in heart sections of
noninfected and chronically T. cruzi-infected monkeys (20–23 ypi). (H) Detection of CK-MB activity in the serum of noninfected and chronically T.
cruzi-infected monkeys (20–23 ypi). (I) Correlation between the number of iNOS/NOS2
+ cells in heart tissue and CK-MB activity levels in serum of
rhesus monkeys. Bar=100 mm.
doi:10.1371/journal.pntd.0001644.g004
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2/2 murine model. Initially, T. cruzi
infection of C57BL/6 mice (the Nos2
2/2 genetic background) led
to increased systemic NO production and, particularly, iNOS/
NOS2
+ cells in the cardiac tissue, which reproduced our findings
in chronically infected monkeys. In addition, iNOS/NOS2
+ cells
have previously been detected in the cardiac tissue of acutely
infected mice [9] and dogs [37]. Therefore, the present data show
that independent of the host and the phase of infection, T. cruzi
Figure 5. iNOS/NOS2 and NO status influence heart parasitism and cardiomyocyte integrity in T. cruzi-infected mice. The mice were
infected with 100 blood trypomastigotes of the Colombian T. cruzi strain and analyzed at 40 dpi. The presence of iNOS/NOS2
+ cells, parasite nests,
inflammatory cells and Cx43 in the myocardium was immunohistochemically detected, NO concentration was evaluated by a Griess-based method
and CK-MB activity levels in the serum was biochemically determined. (A) Increased NO levels in serum of T. cruzi-infected C57BL/6 mice in
comparison with noninfected controls (NI). (B) Photomicrograph of iNOS/NOS2
+ cells in the cardiac tissue of infected C57BL/6 mice and
quantification of iNOS/NOS2
+ cells in the cardiac tissue of infected C57BL/6 mice in comparison with noninfected controls. (C) Photomicrographs and
quantification of parasite nests showing increased heart parasitism in Nos2
2/2 compared with T. cruzi-infected C57BL/6 mice. (D) Similar number of
inflammatory cells in the heart tissue of C57BL/6 and Nos2
2/2 T. cruzi-infected mice. (E) CK-MB activity levels in the serum of noninfected and T. cruzi-
infected mice revealing increased CK-MB activity in T. cruzi-infected mice when compared with noninfected controls. Decreased CK-MB activity in the
serum of Nos2
2/2 compared with C57BL/6 T. cruzi-infected mice. (F) Preserved expression of Cx43 in the heart tissue of Nos2
2/2 compared with
C57BL/6 infected mice. Analysis at 40 dpi of 3–5 noninfected and 5–8 infected mice/group. * p,0.05 and ** p,0.01. Bar=100 mm( C). Bar=50 mm
(F).
doi:10.1371/journal.pntd.0001644.g005
iNOS and NO in Chagas’ Heart Disease
www.plosntds.org 12 May 2012 | Volume 6 | Issue 5 | e1644infection enhances NO in serum and iNOS/NOS2
+ cells in the
cardiac tissue. The present data also refute the result showing that
iNOS/NOS2 is not required for T. cruzi control [12], but support
previous findings that iNOS/NOS2 is essential for T. cruzi control
in the cardiac tissue [9,11]. Paradoxically, NO might be
detrimental in T. cruzi infection because it depresses lymphocyte
functions, which could promote parasite survival [7]. Although this
idea demands further experimental support, if this is the case the
detrimental effect of NO on the immune response may explain
parasite persistence in chronically infected individuals, including
patients [6] and our experimental models. Interestingly, iNOS/
NOS2 absence (in Nos2
2/2) abolished NO production in T. cruzi-
infected mice, which showed that iNOS/NOS2 is essential for NO
overproduction. In addition, this result corroborated studies
showing that there is no compensation mechanism increasing
other NOS isoforms in Chagas disease [12]. Furthermore, iNOS/
NOS2 and locally produced NO are not involved in myocarditis
formation, which suggests that the nature rather than the intensity
of heart inflammation is determinant of the Chagas’ heart disease
outcome [27]. Furthermore, T. cruzi infection of Nos2
2/2 mice
demonstrated a role for iNOS/NOS2 in myocardial cell lesion
and connectivity loss, which supported our findings in chronically
infected monkeys. Interestingly, recent proposal brings support for
Chagas disease to be considered a junctionopathy [38]. Therefore,
iNOS/NOS2-derived NO may be a direct or indirect critical
trigger of the molecular pathway leading to myocardial cell
connectivity loss. Further, T. cruzi may directly lead to myocardial
cell lesion, as revealed by increased CK-MB activity levels in
serum and Cx43 loss, in infected mice. In this context, absence of
iNOS/NOS2 led to significant decrease in CK-MB activity levels
in serum, placing iNOS/NOS2-derived NO as important
myocardiotoxic agent, but did not completely abolished myocar-
dial cell lesion that persisted in presence of high cardiac tissue
parasitism in acutely T. cruzi-infected Nos2
2/2 mice. In chronically
infected rhesus monkeys, focal persistence of T. cruzi (revealed by
detection of antigen
+ spots and of low amounts of parasite DNA)
may contribute to maintain iNOS/NOS2 induction and local NO
production leading to myocardial cell lesion. A previous study
showed that iNOS/NOS2-derived NO was associated with right
ventricular dilation and systolic dysfunction in acute murine T.
cruzi-elicited myocarditis [9]. Although NOS/NOS2 deficiency led
to bradyarrhythmia in noninfected controls, T. cruzi-infected
Nos2
2/2 mice presented lower frequency of AVB1 and AVB2
than T. cruzi-infected C57BL/6 mice. More importantly, the
higher QRS scores detected in CCC patients [2,23], which were
reproduced in infected monkeys and C57BL/6 mice, were
significantly decreased in T. cruzi-infected Nos2
2/2 mice, which
implicated iNOS/NOS2 and NO in QRS score increases
independent of the host. Therefore, the present data support that
the iNOS/NOS2-NO pathway participates in T. cruzi-induced
myocardial cell lesion and heart injury and suggest that this
pathway should be explored as a therapeutic target in CCC.
Considering observations in chronic Chagas disease [6], it is a
plausible proposal as the pivotal role of NO in T. cruzi control was
restricted to acute infection [39]. Further studies are needed to
determine whether inhibition of iNOS/NOS2 will be therapeu-
tically useful in chronic Chagas disease, a condition of vast
overproduction of NO.
Supporting Information
Figure S1 Representative electrocardiographic regis-
ters of chronically T. cruzi-infected rhesus monkeys.
Rhesus monkeys were infected with metacyclic trypomastigotes of
the Colombian T. cruzi strain and analyzed at 20–23 years post-
infection (ypi). (A) ECG registers of monkey # 64 (23 ypi) showing
normal pattern of electrical activity. (B) ECG registers of monkey
# 99 (20 ypi) showing normal pattern. (C) ECG registers of
monkey # 103 (20 ypi) demonstrating first degree right bundle
branch block (RBBB1, arrow). (D) ECG registers of monkey # 90
(20 ypi) showing first degree left bundle branch block (LBBB1,
arrow). (E) ECG registers of monkey # 95 (20 ypi) showing second
degree right bundle branch block (RBBB2, arrow) and right QRS
axis deviation (RAD, arrow head).
(TIF)
Figure S2 Histological alterations in the myocardium of
T. cruzi-infected rhesus monkeys. Sections of the myocar-
dium of the left ventricle of noninfected and T. cruzi-infected
rhesus monkeys were stained with H&E and analyzed under light
microscope. Photomicrographs of heart tissue sections showing: (A)
Monkey #42 (20 ypi), with multifocal infiltrates of mononuclear
inflammatory cells. (B) Monkey #64 (23 ypi), intense focal
mononuclear inflammation. (C) Monkey #99 (20 ypi), normal
aspect of the myocardium. (D) Monkey #103 (20 ypi), multifocal
Table 2. Electrocardiograph parameters of C57BL/6 and Nos2
2/2 mice infected with the Colombian T. cruzi strain.
Experimental
groups
Heart rate
{
(bpm)
PR interval
(ms)
P-wave
duration (ms)
QRS
duration (ms) QTc (ms) Cardiac conduction (% of mice)
{
C56BL/6 NI 530628.1 35.862.1 12.361.4 11.160.4 16.362.2 Brad (0%) AVB1 (0%) AVB2 (0%)
C57BL/6 T. cruzi 441638.5
** 41.160.4
*** 12.560.9 18.661.5
*** 32.262.7
*** Brad (43%) AVB1 (57%) AVB2 (43%)
Nos2
2/2 NI 400663.8
11 36.564.0 14.061.0 11.161.1 20.761.7
11 Brad (60%) AVB1 (20%) AVB2 (0%)
Nos2
2/2 T. cruzi 423681.9 39.664.3 14.062.3 13.962.4
*,### 28.369.8 Brad (57%) AVB1 (43%) AVB2 (28%)
{ECG parameters were evaluated at 40 dpi, using the following standard criteria: (i) heart rate (monitored by beats per minute (bpm), and (ii) the variation of the P wave
and PR, QRS and QT intervals, all measured in milliseconds (ms); Brad, bradycardia; AVB1, first-degree atrioventricular block; AVB2, second-degree atrioventricular block.
{These data represent two independent experiments, with 5–7 mice/group.
1,p ,0.05;
11,p ,0.01; comparison between the values for C57BL/6 and Nos2
2/2 noninfected groups of mice;
*, p,0.05;
**, p,0.01;
***, p,0.001; comparison between the values for noninfected and T. cruzi-infected groups of mice;
#,p ,0.05;
##,p ,0.01;
###,p ,0.001; comparison between the values for C57BL/6 and Nos2
2/2 T. cruzi-infected mice.
doi:10.1371/journal.pntd.0001644.t002
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ypi), normal aspect of the myocardium. (F) Monkey #95 (20 ypi),
multifocal infiltrates of mononuclear inflammatory cells. (G)
Noninfected monkey #94, normal aspect. H&E. Bar=100 mm.
(TIF)
Figure S3 Total IgM and IgG levels in noninfected and
chronically T. cruzi-infected rhesus monkeys. The levels
of total immunoglobulins of the IgM and IgG classes were
determined by nephrolometry in the serum of noninfected and T.
cruzi-infected rhesus monkeys at the end point (20–23 years post-
infection, ypi). Total (A) IgM and (B) IgG levels in the serum.
(TIF)
Figure S4 Representative electrocardiographic regis-
ters of T. cruzi-infected C57BL/6 and Nos2
2/2 mice.
The mice were infected with 100 blood trypomastigotes of the
Colombian T. cruzi strain and analyzed at 40 dpi. (A) ECG
registers of noninfected control C57BL/6 mice showing normal
pattern of electrical activity. (B) ECG registers of T. cruzi-infected
C57BL/6 mice showing first- and second-degree atrioventricular
block (AVB1, AVB2, arrows). (C) ECG registers of noninfected
control Nos2
2/2 mice showing presence of sinus bradyarrhythmia.
(D) ECG registers of T. cruzi-infected Nos2
2/2 mice showing first
degree atrioventricular block (AVB1, arrows).
(TIF)
Table S1 General characterization of Trypanosoma
cruzi infection of rhesus monkeys. Rhesus monkeys were
infected with metacyclic trypomastigote forms of the Colombian
T. cruzi strain and analyzed at 20–23 years post-infection (ypi). The
original colony identification used in the present study and the
experimental number used in a previous publication that describes
the analysis of the T. cruzi- infected monkeys during the acute
infection, are provided.
(DOC)
Table S2 Echocardiographic patterns detected in Try-
panosoma cruzi-infected rhesus monkeys during chron-
ic infection. Rhesus monkeys were infected with metacyclic
trypomastigotes of the Colombian T. cruzi strain and analyzed at
20–23 years post-infection (ypi). The echocardiographic registers
were analyzed and the main findings were asynchronic interven-
tricular septum motility and decreased left ventricular ejection
fraction detected in monkey #95.
(DOC)
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